Differential competitive resistance to methylating versus chloroethylating agents among five 'O POT.6'-alkylguanine DNA alkyltransferases in human hematopoietic cells (2006)
- Authors:
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; ZAGO, MARCO ANTONIO - FMRP
- Unidade: FMRP
- DOI: 10.1158/1535-7163.mct-05-0236
- Subjects: GENÉTICA; NEOPLASIAS
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2006
- Source:
- Título: Molecular Cancer Therapeutics
- ISSN: 1535-7163
- Volume/Número/Paginação/Ano: v. 5, n. 1, p. 121-128, 2006
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
FONTES, Aparecida Maria et al. Differential competitive resistance to methylating versus chloroethylating agents among five 'O POT.6'-alkylguanine DNA alkyltransferases in human hematopoietic cells. Molecular Cancer Therapeutics, v. 5, n. 1, p. 121-128, 2006Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.mct-05-0236. Acesso em: 13 mar. 2026. -
APA
Fontes, A. M., Davis, B. M., Encell, L. P., Lingas, K., Covas, D. T., Zago, M. A., et al. (2006). Differential competitive resistance to methylating versus chloroethylating agents among five 'O POT.6'-alkylguanine DNA alkyltransferases in human hematopoietic cells. Molecular Cancer Therapeutics, 5( 1), 121-128. doi:10.1158/1535-7163.mct-05-0236 -
NLM
Fontes AM, Davis BM, Encell LP, Lingas K, Covas DT, Zago MA, Loeb LA, Pegg AE, Gerson SL. Differential competitive resistance to methylating versus chloroethylating agents among five 'O POT.6'-alkylguanine DNA alkyltransferases in human hematopoietic cells [Internet]. Molecular Cancer Therapeutics. 2006 ; 5( 1): 121-128.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1158/1535-7163.mct-05-0236 -
Vancouver
Fontes AM, Davis BM, Encell LP, Lingas K, Covas DT, Zago MA, Loeb LA, Pegg AE, Gerson SL. Differential competitive resistance to methylating versus chloroethylating agents among five 'O POT.6'-alkylguanine DNA alkyltransferases in human hematopoietic cells [Internet]. Molecular Cancer Therapeutics. 2006 ; 5( 1): 121-128.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1158/1535-7163.mct-05-0236 - Caracterização molecular do vírus HTLV-2
- Um modelo para estudos de diferenciação celular em células-tronco pluripotentes utilizando-se de análises imunofenotípicas e morfométricas
- Optimizing PBSC collection time using circulating CD34+ cell counts
- Molecular mechanisms involved in T-cell supression and regulatory T cell generation by mesenchymal stromal cells
- Transfusion risk HIV in the Northern region of the state of São Paulo - Brazil
- DGGE (denaturing gradient gel eletrophoresis) como método de "screening" das variações do gene da G6PD
- Inhibition of expression of HTLV-1 structural genes mediated by short hairpin RNA in vitro
- DGGE (Denaturing Gradient Gel Eletrophoresis) como método de "SCREENING" das hemoglobinopatias
- Hydroxyurea treatment reduces the exposure of phosphatidylserine on erythrocytes and platelets in sickle cell anemia
- Presence of facilitating cells for homing and engraftment in Cord Blood
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
